Sunshine Biopharma, Inc. (SBFM) News
Track canonical SquawkNews coverage tagged to SBFM, Sunshine Biopharma, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 15 indexed stories across 10 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Sunshine Biopharma Inc. (SBFM) Launches Generic Ondansetron in Canada
Sunshine Biopharma Inc. launched generic Ondansetron 4mg and 8mg film—coated tablets in Canada via Nora Pharma, expanding its oncology supportive care lineup.Material DetailsContext by AI AnalystThis is a mid-cycle portf
NEWS | Sep 24, 2026, 01:01 PM UTC
L
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
FORT LAUDERDALE, FL / / September 24, 2026 / Sunshine Biopharma Inc. NASDAQ:SBFM (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications including drugs in the are
NEWS | Sep 24, 2026, 01:01 PM UTC
L
SBFM - Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
SBFM - Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
NEWS | Sep 24, 2026, 01:00 PM UTC
L
SBFM - Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
SBFM - Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
NEWS | Sep 16, 2026, 01:00 PM UTC
H
EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies
Sunshine Biopharma Inc. (NASDAQ: SBFM ) on Wednesday announced it advanced its lead Coronavirus drug candidate into IND-enabling studies. The company had previously published laboratory results on its library of compound
LIVE | Sep 16, 2026, 12:31 PM UTC
M
Sunshine Biopharma: Health Canada approves atenolol for cardiovascular conditions
Sunshine Biopharma says Health Canada approved atenolol for treating cardiovascular conditions.
EQUITY | Aug 31, 2026, 02:31 PM UTC
L
Dr. Andrew Keller to Leave Sunshine Biopharma Board at Term End
Dr. Andrew Keller to Leave Sunshine Biopharma Board at Term End
EQUITY | Aug 28, 2026, 08:15 PM UTC
L
Sunshine Biopharma advances mRNA cancer vaccine strategy for lung cancer
SBFM says its in vivo work shows tumor suppression with K1.1 mRNA and it is advancing a novel mRNA vaccine strategy for lung cancer.
EQUITY | Aug 26, 2026, 01:00 PM UTC
L
Sunshine Biopharma advances K1.1 mRNA cancer-vaccine strategy
Sunshine Biopharma says it has reported in vivo tumor suppression with K1.1 mRNA and advanced a novel mRNA-cancer vaccine strategy for lung cancer.
EQUITY | Aug 26, 2026, 01:00 PM UTC
L
Sunshine Biopharma gets Canadian approval for enalapril
Sunshine Biopharma (SBFM) says it received Canadian regulatory approval for enalapril, positioning the company to expand within a stated $25.94 billion global anti-hypertensive drug market.
REGULATION | Aug 19, 2026, 01:00 PM UTC
L
SBFM - Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
SBFM - Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
EQUITY | Aug 04, 2026, 01:00 PM UTC
L
SBFM - Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
SBFM - Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
EQUITY | Jul 28, 2026, 12:00 PM UTC
L
SBFM Sunshine Biopharma - enters at-the-market sales agreement with aegis capital for up to $4M - SEC filing
SBFM Sunshine Biopharma - enters at-the-market sales agreement with aegis capital for up to $4M - SEC filing
REGULATION | Jul 20, 2026, 08:29 PM UTC
M
SBFM Gets Canada Approval
Sunshine Biopharma announces approval of generic Anastrozole tablets for Canadian market
EQUITY | Jun 25, 2026, 12:04 PM UTC
M
SBFM Receives Approval
Sunshine Biopharma receives Canadian regulatory approval for generic Arimidex
EQUITY | Jun 25, 2026, 12:01 PM UTC